Trial results for a study investigating a home-based behavioral activation treatment for Type 2 Diabetes were posted on ClinicalTrials.gov on 2026-02-24. The intervention group demonstrated a mean HbA1c of 8.8% compared to 9.0% in the control group.
Background
Type 2 Diabetes is a chronic condition characterized by high blood sugar levels. For low-income, ethnic minority seniors with poorly controlled Type 2 Diabetes, accessible and culturally sensitive interventions are crucial. This study aimed to evaluate a home-based, telephone-delivered behavioral activation treatment designed to improve glycemic control in this specific demographic.
Trial design
This completed study, designated as Phase NA, enrolled 200 participants with Type 2 Diabetes. The trial's objective was to evaluate the efficacy and cost-effectiveness of 8 sessions of in-home, telephone-delivered, culturally-modified, manualized diabetes-modified behavioral activation treatment (Home DM-BAT). This intervention was delivered by trained diabetes nurse educators to low-income, ethnic minority seniors with poorly controlled Type 2 Diabetes. The primary aim was to test the efficacy of Home DM-BAT on glycemic control, measured by hemoglobin A1c. Participants were randomized to either the Home DM-BAT intervention group or a control group (GHE+ST).
Key results
The trial reported key measurements for glycemic control (HbA1c):
- For the Home DM-BAT Intervention group, the mean percentage of HbA1c was 8.8 (Standard Error 0.2).
- For the Control Group (GHE+ST), the mean percentage of HbA1c was 9.0 (Standard Error 0.2).
What this means
The results indicate that the Home DM-BAT intervention group achieved a slightly lower mean HbA1c percentage compared to the control group. This suggests a potential benefit of this home-based, telephone-delivered behavioral activation treatment for improving glycemic control in low-income, ethnic minority seniors with poorly controlled Type 2 Diabetes. While the difference is numerically small, it highlights the potential for accessible, culturally-modified interventions in managing chronic conditions within vulnerable populations.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04203147, titled "Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM", were posted on 2026-02-24 on clinicaltrials.gov.